EN DE
Watch Town Health International Medical Group Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Town Health International Medical Group Limited (3886) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Town Health International Medical Group Limited stock HK$0.09, price HK$0.18, that is 50.0% below the price, quality 62 out of 100. Rating: strongly overvalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare HK · ISIN BMG8979V1046

TH Town Health International Medical Group Limited logo Thin data Nov 12, 2026

Town Health International Medical Group Limited

3886 · HK

Far too expensive (fair value 50% below the price) and falling price, but solid company: meets 1 of 3 rules.

Get notified free when this changes
Quality 62/100 
Low debt 
Generates free cash flow 
1.1% dividend yield · Sustainable
Mixed Growth (revenue 5y +10.8 %/yr in HKD) 
Thin margins · 0.8% net margin (TTM) 
Fair value HK$0.0900 · Strongly overvalued 
Falling price (downtrend) 
Trails peers (3/12) 
Narrow moat 25/100 · thin data
Thin data 
Watch Town Health International Medical Group Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$0.6727 HK$0.1500 Fair Value HK$0.0900 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.

How to read this chart

60‑month range HK$0.1500 – HK$0.6727 · fair‑value band HK$0.0700 – HK$0.1100 · the HK$0.1800 price screens above the HK$0.0900 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 12, 2026.

Follow Town Health International Medical Group in your weekly email

Every Wednesday you see whether Town Health International Medical Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Town Health International Medical Group Limited, an investment holding company, provides healthcare and related services in the People's Republic of China and Hong Kong.

Show moreShow less

It operates through four segments: Hong Kong Medical Services; Hong Kong Managed Medical Network Business; Mainland Hospital Management and Medical Services; and Others.

The company provides medical healthcare, managed medical network, dental consultation, eyecare, private specialty healthcare, third party medical network administrator, and laboratory testing services.

It also offers specialty services that covers cardiology, clinical oncology, dermatology, gastroenterology and hepatology, weight management and diabetes, neurosurgery, obstetrics and gynaecology, ophthalmology, orthopaedics, otorhinolaryngology, paediatrics, plastic surgery, psychiatry, urology, and nephrology; and dental services, such as general dentistry, prosthodentics, periodontology, oral and maxillofacial surgery, endodontics, orthodontics and paediatric dentistry etc.

In addition, the company provides health check, and diagnostics and imaging services, such as PET- CT, MRI, CT, ultrasound scanning, endoscopy, cardiological examination, breast imaging, DEXA bone densitometry, X-Ray, lung function test, fundus photography, audiological test and full range laboratory service, etc.; physiotherapy services; traditional chinese medicine services; and medical beauty, body management, and life beauty services.

Further, it offers property investment and management, hospital and health management, and business and corporate advisory services, as well as leases properties; and engages in the trading of medical consumables and equipment, and medicines.

The company was formerly known as Town Health International Investments Limited and changed its name to Town Health International Medical Group Limited in March 2014. Town Health International Medical Group Limited was founded in 1989 and is headquartered in Sha Tin, Hong Kong.

Stock analysis

Town Health International Medical Group Limited (3886) currently trades at HK$0.1800, while our model-based Fair Value estimate is HK$0.0900, 50% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of HK$0.3700 per share, and 3 of the 24 models we run sit above the HK$0.1800 price.

Bear case: the Earnings-Based group reads lowest at HK$0.0350, and 21 of the 24 models stay below the price. Data coverage for this calculation is low.

Scenario range: HK$0.0700 (bear) to HK$0.1100 (bull), the price of HK$0.1800 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 62/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Town Health International Medical Group Limited reported revenue of HK$1.8B in FY2025 versus HK$1.5B in FY2021, a compound +4.7%/yr. Reported net income was HK$14.4M in FY2025, compounding −10.1%/yr from FY2021.

Key figures

Market cap HK$1.2B (≈ $155M) Micro · P/S ratio 0.63 · Dividend yield 1.1% · Net margin 0.8% · Return on equity 1.9% · Return on assets (EBIT) 1.3% (5-year average) · Operating margin 4.0% · Revenue (TTM) HK$1.8B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 25 out of 100 (low confidence).

What moves the price

The share trades about 33% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at −50%, 3886 screens richer than that median.

Fair Value models

Bear HK$0.0700 Fair Value HK$0.0900 Bull HK$0.1100
Price HK$0.1800 · Downside -50.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF HK$0.0800 HK$0.0900 HK$0.1200 81
Growth DCF HK$0.0800 HK$0.0900 HK$0.1100 79
Owner Earnings HK$0.0800 HK$0.1000 HK$0.1300 77
All 25 models by family
DCF Models
FCF DCF HK$0.0800 HK$0.0900 HK$0.1200 81
Owner Earnings HK$0.0800 HK$0.1000 HK$0.1300 77
5Y Revenue Exit HK$0.0700 HK$0.0800 HK$0.1000 73
5Y EBITDA Exit HK$0.0900 HK$0.1300 HK$0.1800 75
5Y P/E Exit HK$0.0700 HK$0.0900 HK$0.1100 71
10Y Revenue Exit HK$0.0700 HK$0.0800 HK$0.1000 67
10Y EBITDA Exit HK$0.0800 HK$0.1100 HK$0.1500 68
10Y P/E Exit HK$0.0700 HK$0.0900 HK$0.1100 64
Earnings-Based
Graham-Dodd HK$0.0100 HK$0.0600 HK$0.0800 64
Lynch FV HK$0.0200 HK$0.0200 HK$0.0300 61
PEG = 1.0 HK$0.0200 HK$0.0200 HK$0.0300 57
EPV HK$0.0500 HK$0.0500 HK$0.0500 73
Dividend Discount
Gordon GGM n/a n/a HK$0.0100 65
Multiples
P/E Multiple HK$0.0400 HK$0.0500 HK$0.0600 63
P/S Multiple HK$0.0300 HK$0.0400 HK$0.0500 57
P/B Multiple HK$0.3500 HK$0.4700 HK$0.5900 55
EV/EBIT HK$0.0700 HK$0.0800 HK$0.0900 65
EV/EBITDA HK$0.1100 HK$0.1300 HK$0.1500 67
EV/Revenue HK$0.0600 HK$0.0700 HK$0.0800 53
Asset-Based
NCAV (Graham) HK$0.2500 HK$0.3700 HK$0.4700 54
Growth DCF
Growth DCF HK$0.0800 HK$0.0900 HK$0.1100 79
Rev-Margin DCF HK$0.0700 HK$0.0800 HK$0.1000 73
Economic Profit
Residual Income HK$0.2000 HK$0.2200 HK$0.2600 76
ROIC Compounder HK$0.0500 HK$0.0500 HK$0.0500 71
Growth Earnings
Growth-Adj P/E HK$0.0300 HK$0.0400 HK$0.0500 68

Open the full fair value analysis →

Quality Score breakdown

Overall quality 62/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 19
How much profit the company makes from its sales and capital
Quality Growth 48
Are margins and returns getting better?
Cashflow 67
Do the profits arrive as real cash?
Financial strength 76
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 67
How calm the share price moves, does not count
Price momentum 23
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 13
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 72/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−2.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.8%
Start year 2020 (pandemic). Over 10 years: +4.7% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.5%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+0.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−0.4%
Dividend (yield on the price)1.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−0.4% vs −19.3%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−23% → 4%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.

3886 screens overvalued: fair value 50% below the price. Compare with HCA Healthcare, Inc →

Compare Town Health International Medical Group Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks

Beats the industry median on 2/11 measures
Overall it trails its industry peers.
Valuation
Quality Score 62 · Above median
Fair Value upside −50.0% · Bottom 25%
Profitability
Return on equity (12 months) 1.9% · Below median
Return on assets 1.6% · Below median
Net margin (12 months) 3.7% · Below median
Operating margin (12 months) 4.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −2.7% · Bottom 25%
Dividend yield (12 months) 1.1% · Below median

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B 0.41× · Cheapest 25%
P/S (12 months) 3.12× · Priciest 25%
Price / free cash flow (fiscal year) 42.5× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 34
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)8 · sector 31
HEALTH (low debt)100 · sector 90
DIVIDEND (yield)22 · sector 38

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $22.03 $45.73 +108% vs 3886
DaVita Inc DVA $174.56 $218.90 +25% vs 3886
Aier Eye Hospital Group 300015 ¥8.84 ¥10.88 +23% vs 3886
HCA Healthcare, Inc HCA $499.05 $547.34 +10% vs 3886
Tenet Healthcare Corporation THC $286.03 $279.20 −2% vs 3886
The Ensign Group ENSG $188.41 $140.09 −26% vs 3886
Encompass Health Corporation EHC $140.99 $94.81 −33% vs 3886
Fresenius SE FRE €53.62 €34.77 −35% vs 3886
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,526 ₹5,234 −39% vs 3886
Dr. Sulaiman Al Habib Medical Services Group 4013 212.10 SAR 109.45 SAR −48% vs 3886

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Town Health International Medical Group Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Town Health International Medical Group Limited Fair Value". https://www.fairvalue-calculator.com/stock/3886

Frequently asked questions

Is Town Health International Medical Group Limited (3886) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of HK$0.0900 versus a price of HK$0.1800, about 50% lower (overvalued).
What is the fair value of 3886?
Our model-based fair value for Town Health International Medical Group Limited is HK$0.0900 (as of Nov 12, 2026), built from audited fundamentals. The current price: HK$0.1800.
What is the quality score of 3886?
Town Health International Medical Group Limited has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Town Health International Medical Group Limited (3886)?
Our model-based price target is the fair value of HK$0.0900 (as of Nov 12, 2026) from 25 valuation models. Cautious scenario HK$0.0700, optimistic scenario HK$0.1100. It is a calculation from audited fundamentals, not an analyst target.
What is the Town Health International Medical Group Limited stock forecast for 2026?
Our models put fair value at HK$0.0900, about 50% lower versus a price of HK$0.1800 (overvalued). Cautious scenario HK$0.0700, optimistic scenario HK$0.1100. The calculation is refreshed regularly with new filings.
What is the revenue of Town Health International Medical Group Limited (3886)?
Town Health International Medical Group Limited reported trailing-twelve-month revenue of about HK$1.8B (latest available figure, as of Nov 12, 2026).
Does Town Health International Medical Group Limited pay a dividend?
Town Health International Medical Group Limited currently shows a dividend yield of 1.11% relative to its recent price (as of Nov 12, 2026).
How much is the dividend of Town Health International Medical Group Limited (3886) and when is the ex-dividend date?
Town Health International Medical Group Limited pays a dividend of HK$0.002 per share a year, a dividend yield of 1.1%. The last ex-dividend date was Jun 24, 2026. A dividend has been paid every year since 2022. The payout ratio is 94.2% of earnings. Free cash flow covers the dividend 9.54 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Town Health International Medical Group Limited (3886)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at Town Health International Medical Group Limited shrinks by more than 40 % per year for five years (discount rate 13.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 10.8 % per year. As of Nov 12, 2026.
What discount rate (WACC) does the fair value of 3886 use?
Our models discount Town Health International Medical Group Limited at 13.3 %: a base by market capitalisation (micro), country premium for Hong Kong. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Town Health International Medical Group Limited that is less than minus 40 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.3 %) and the same formula as our fair value.
How much growth has Town Health International Medical Group Limited (3886) delivered so far?
Over the past 5 years revenue at Town Health International Medical Group Limited grew 10.8 % a year. The price currently implies free-cash-flow growth of less than minus 40 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Town Health International Medical Group Limited (3886) growing?
The median revenue growth in the sector is +5.9 % a year. That is the yardstick for the growth priced into Town Health International Medical Group Limited (less than minus 40 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Town Health International Medical Group Limited (3886)?
The free-cash-flow yield on the price is 10.60 %: that much free cash flow Town Health International Medical Group Limited produces per unit of market value. When it exceeds the discount rate of our models (13.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Town Health International Medical Group Limited (3886)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Town Health International Medical Group Limited it is HK$0.0900 per share (as of Nov 12, 2026), against a price of HK$0.1800. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Town Health International Medical Group Limited stock overvalued or undervalued in 2026?
As of Nov 12, 2026, 3886 trades above its calculated fair value: price HK$0.1800, fair value HK$0.0900, a gap of about −50% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3886?
No. The price is what the market pays today (HK$0.1800); the fair value is what the company's own numbers justify (HK$0.0900). For Town Health International Medical Group Limited the two are HK$0.0900 per share apart. That gap is exactly why we show both numbers side by side.
How much is Town Health International Medical Group Limited worth?
The market values Town Health International Medical Group Limited at about HK$1.2B (market capitalisation, as of Nov 12, 2026). Per share that is HK$0.1800; our models calculate a fair value of HK$0.0900 per share.
What do the bullish and bearish scenarios say about 3886?
Our models span a range for Town Health International Medical Group Limited: cautious scenario HK$0.0700, base HK$0.0900, optimistic HK$0.1100 per share (as of Nov 12, 2026, price HK$0.1800). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Town Health International Medical Group Limited (3886)?
Balance-sheet figures for Town Health International Medical Group Limited (as of Nov 12, 2026): return on equity 1.9%. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is 3886 from its 52-week high?
Town Health International Medical Group Limited trades at HK$0.1800, about 33% below its 52-week high of HK$0.2678 and 20% above the low of HK$0.1500 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.0900 is for.
Which stocks are comparable to Town Health International Medical Group Limited?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Town Health International Medical Group Limited stock attractive at the current price?
The data as of Nov 12, 2026: price HK$0.1800, calculated fair value HK$0.0900 (−50%), Quality Score 62/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3886 calculated?
We run Town Health International Medical Group Limited through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of HK$0.0900 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Town Health International Medical Group Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Town Health International Medical Group Limited (3886)?
The closing price on Nov 13, 2026 was HK$0.1800. Our model-based fair value is HK$0.0900, about 50% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Town Health International Medical Group Limited right now?
The price sits above even our optimistic bull case (HK$0.1100). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Town Health International Medical Group Limited

How large is the market capitalisation of Town Health International Medical Group Limited (3886)?
The market capitalisation of Town Health International Medical Group Limited is HK$1.2B (≈ $155M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Town Health International Medical Group Limited (3886)?
The price-to-sales ratio of Town Health International Medical Group Limited is 0.63 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Town Health International Medical Group Limited (3886)?
The dividend yield of Town Health International Medical Group Limited is 1.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Town Health International Medical Group Limited (3886)?
The net margin of Town Health International Medical Group Limited is 0.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Town Health International Medical Group Limited (3886)?
The return on equity (ROE) of Town Health International Medical Group Limited is 1.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Town Health International Medical Group Limited (3886)?
On an EBIT basis the return on assets of Town Health International Medical Group Limited is 1.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Town Health International Medical Group Limited (3886)?
The operating margin of Town Health International Medical Group Limited is 4.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Town Health International Medical Group Limited (3886)?
Revenue at Town Health International Medical Group Limited is down 2.7% versus a year earlier (3y avg +5.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Town Health International Medical Group Limited (3886)?
Earnings per share at Town Health International Medical Group Limited are growing 1.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Town Health International Medical Group Limited (3886) hold?
Town Health International Medical Group Limited holds more cash than debt, HK$1.0B net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Town Health International Medical Group Limited in the live analysis

One click puts Town Health International Medical Group Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.